Perceptions and use of complementary and alternative medicine in patients with precocious puberty
-
Sevinc Odabasi Gunes
Abstract
Objectives
Use of complementary and alternative medicine (CAM) is widespread. This study aimed to investigate the use of CAM in children with central precocious puberty (PP) who used gonadotropin-releasing hormone analog (GnRHa) treatment.
Methods
Parents of 108 patients who were diagnosed as having PP were involved in the study. A questionnaire was administered to the parents during follow-ups. The patients were divided into two groups according to the use of CAM.
Results
Forty (37%) patients had used CAM. Parents who graduated from primary school tended not to use CAM (χ 2 =10.463; p=0.015). There was no other statistically significant difference between the sociodemographic features (p>0.05). The most common information source was physicians (40%). Seventy-five percentage of CAM users and 44.1% of non-CAM users knew/heard about herbal medicine (χ 2 =8.517; p=0.004) and herbal medicine was the most common type of CAM used. 80% of parents in the CAM group and 54.4% of parents in the non-CAM group knew at least one biologically based therapy that had estrogenic activity (χ 2 =6.082; p=0.014). Seventy-one percentage of parents in the CAM group and 29% of parents in the non-CAM group stated that they would consider using CAM in the future (χ 2 =16.979; p<0.001).
Conclusions
The use of CAM among patients with PP is high. Although most CAM therapies are harmless, there may be adverse effects or drug interactions with current conventional treatment in children. Health professionals should be aware and inquire about the use and type of CAM, considering the medical history at every patient encounter.
-
Research funding: None declared.
-
Author contributions: The author has accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Author states no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The local Ethics Committee approved the study (Date: August 23, 2020, Protocol No.: 2020-285).
References
1. Latronica, AC, Brit, VN, Carel, JC. Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol 2016;4:265–74. https://doi.org/10.1016/s2213-8587(15)00380-0.Suche in Google Scholar PubMed
2. Day, FR, Elks, CE, Murray, A, Ong, KK, Perry, JRB. Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: the UK Biobank study. Sci Rep 2015;5:11208. https://doi.org/10.1038/srep11208.Suche in Google Scholar PubMed PubMed Central
3. Cheng, TS, Day, FR, Lakshman, R, Ong, KK. Association of puberty timing with type 2 diabetes: a systematic review and meta-analysis. PLoS Med 2020;17:e1003017. https://doi.org/10.1371/journal.pmed.1003017.Suche in Google Scholar PubMed PubMed Central
4. Graber, JA. Pubertal timing and the development of psychopathology in adolescence and beyond. Horm Behav 2013;64:262–9. https://doi.org/10.1016/j.yhbeh.2013.04.003.Suche in Google Scholar PubMed
5. Mendle, J, Harden, KP, Brooks-Gunn, J, Grabber, JA. Development’s tortoise and hare: pubertal timing, pubertal tempo and depressive symptoms in boys and girls. Dev Psychol 2010;46:1341–53. https://doi.org/10.1037/a0020205.Suche in Google Scholar PubMed PubMed Central
6. Eugster, EA. Treatment of central precocious puberty. J Endocr Soc 2019;3:965–72. https://doi.org/10.1210/js.2019-00036.Suche in Google Scholar PubMed PubMed Central
7. Carel, JC, Eugster, EA, Rogol, A, Ghizzoni, L, Palmert, MR, on behalf of the ESPE-LWPES GnRH Analogs Consensus Conference Group. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:e752–62. https://doi.org/10.1542/peds.2008-1783.Suche in Google Scholar PubMed
8. Barnes, PM, Bloom, B, Nahin, RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008;12:1–23.10.1037/e623942009-001Suche in Google Scholar
9. Adams, D, Dagenais, S, Clifford, T, Baydala, L, King, JW, Hervas-Malo, M, et al.. Complementary and alternative medicine use by pediatric specialty outpatients. Pediatrics 2013;131:225–32. https://doi.org/10.1542/peds.2012-1220.Suche in Google Scholar PubMed
10. Harris, PE, Cooper, KL, Relton, C, Thomas, KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract 2012;66:924–39. https://doi.org/10.1111/j.1742-1241.2012.02945.x.Suche in Google Scholar PubMed
11. Posadzki, P, Watson, LK, Alotaibi, A, Ernst, E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med 2013;13:126–31. https://doi.org/10.7861/clinmedicine.13-2-126.Suche in Google Scholar PubMed PubMed Central
12. Black, LI, Clarke, TC, Barnes, PM, Stussman, BJ, Nahin, RL. Use of complementary health approaches among children aged 4-17 years in the United States: National Health Interview Survey, 2007–2012. Natl Health Stat Report 2015;78:1–19.Suche in Google Scholar
13. Haliloglu, B, Isguven, P, Yildiz, M, Arslanoglu, I, Erguven, M. Complementary and alternative medicine in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol 2011;3:139–43. https://doi.org/10.4274/jcrpe.v3i3.27.Suche in Google Scholar PubMed PubMed Central
14. Tuncel, T, Şen, V, Kelekçi, S, Karabel, M, Şahin, C, Uluca, U, et al.. Use of complementary and alternative medicine in children who have no chronic disease. Turk Pediatri Ars 2014;49:148–53. https://doi.org/10.5152/tpa.2014.1498.Suche in Google Scholar PubMed PubMed Central
15. Erdol, S, Sağlam, H. Use of complementary and alternative medicine in patients with inherited metabolic disease. J Pediatr Endocrinol Metab 2018;31:1091–8. https://doi.org/10.1515/jpem-2018-0165.Suche in Google Scholar PubMed
16. Ozturk, C, Karatas, H, Langler, A, Schutze, T, Bailey, R, Zuzak, TJ. Complementary and alternative medicine in pediatrics in Turkey. World J Pediatr 2014;10:299–305. https://doi.org/10.1007/s12519-014-0507-8.Suche in Google Scholar PubMed
17. Guven, B, Sag, E, İssi, F, Orhan, F, Cakir, M. Complementary and alternative medicine use in pediatric gastroenterology outpatient clinic: cross-sectional study. Turkiye Klinikleri J Pediatr 2021;30:184–91. https://doi.org/10.5336/pediatr.2021-84922.Suche in Google Scholar
18. Zuzak, TJ, Bonkova, J, Careddu, D, Garami, M, Hadjipanayis, A, Jazbec, J, et al.. Use of complementary and alternative medicine by children in Europe: published data and expert perspectives. Compl Ther Med 2013;21:34–47. https://doi.org/10.1016/j.ctim.2012.01.001.Suche in Google Scholar PubMed
19. Lemaire, P, Pierre, D, Bertrand, JB, Brauner, R. A mathematical model for predicting the adult height of girls with advanced puberty after spontaneous growth. BMC Pediatr 2014;14:172. https://doi.org/10.1186/1471-2431-14-172.Suche in Google Scholar PubMed PubMed Central
20. Calcaterra, V, Sampaolo, P, Klersy, C, Larizza, D, Alfei, A, Brizzi, V, et al.. Utility of breast ultrasonography in the diagnostic work-up of precocious puberty and proposal of a prognostic index for identifying girls with rapidly progressive central precocious puberty. Ultrasound Obstet Gynecol 2009;33:85–91. https://doi.org/10.1002/uog.6271.Suche in Google Scholar PubMed
21. Orhan, F, Sekerel, BE, Kocabas, CN, Sackesen, C, Adalioglu, G, Tuncer, A. Complementary and alternative medicine in children with asthma. Ann Allergy Asthma Immunol 2003;90:611–5. https://doi.org/10.1016/s1081-1206(10)61864-9.Suche in Google Scholar
22. Madsen, H, Andersen, S, Nielsen, RG, Dolmer, BS, Host, A, Damkier, A. Use of complementary/alternative medicine among pediatric patients. Eur J Pediatr 2003;162:334–41. https://doi.org/10.1007/s00431-003-1180-4.Suche in Google Scholar PubMed
23. Goldman, RD, Rogovik, AL, Lai, D, Vohra, S. Potential interactions of drug-natural health products and natural health products-natural health products among children. J Pediatr 2008;152:521–6. https://doi.org/10.1016/j.jpeds.2007.09.026.Suche in Google Scholar PubMed
24. Spigelblatt, L, Laine-Ammara, G, Pless, B, Guyver, A. The use of alternative medicine by children. Pediatrics 1994;94:811–4. https://doi.org/10.1542/peds.94.6.811.Suche in Google Scholar
25. Vos, B, Rake, JP, Vlieger, A. Adverse events associated with pediatric complementary and alternative medicine in The Netherlands: a national surveillance study. Eur J Pediatr 2021;180:2165–71. https://doi.org/10.1007/s00431-020-03899-8.Suche in Google Scholar PubMed
26. Casbarro, N, Ezomo, O, Woolley, K, Smith, R, Hardin, C, Feinn, R, et al.. Complementary and integrative medicine: an observational study on pediatric clinicians’ knowledge, beliefs and practices. Compl Ther Med 2021;58:102693. https://doi.org/10.1016/j.ctim.2021.102693.Suche in Google Scholar PubMed
27. McClafferty, H, Vohra, S, Bailey, M, Brown, M, Esparham, A, Gerstbacher, D, et al.. Pediatric integrative medicine. Pediatrics 2017;140:e20171961. https://doi.org/10.1542/peds.2017-1961.Suche in Google Scholar PubMed
28. Lee, YB, Lee, JA, Lee, HY. Herbal medicine for idiopathic central precocious puberty: a systematic review and meta-analysis. J Alternative Compl Med 2020;26:976–99. https://doi.org/10.1089/acm.2019.0312.Suche in Google Scholar PubMed
29. Bai, G, Hu, K, Huan, Y, Wang, X, Lei, L, Zhang, M, et al.. The traditional Chinese medicine Fuyou formula alleviates precocious puberty by inhibiting GPR54/GnRH in the hypothalamus. Front Pharmacol 2021;11:596525. https://doi.org/10.3389/fphar.2020.596525.Suche in Google Scholar PubMed PubMed Central
30. Park, SC, Trinh, TA, Lee, WY, Baek, JY, Lee, S, Choi, K, et al.. Effects of estrogen inhibition formula herbal mixture for danazol-induced precocious puberty in female rats: an experimental study with network pharmacology. Int Med Res 2021;10:100708. https://doi.org/10.1016/j.imr.2020.100708.Suche in Google Scholar PubMed PubMed Central
31. Yildiz, Y, Yavuz, AY. Complementary and alternative medicine use in children with asthma. Compl Ther Clin Pract 2021;43:101353. https://doi.org/10.1016/j.ctcp.2021.101353.Suche in Google Scholar PubMed
32. Sabry, MM, Abdel-Rahman, RF, El-Shenawy, SM, Hassan, AM, El-Gayed, SH. Estrogenic activity of Sage (Salvia officinalis L.) aerial parts and its isolated ferulic acid in immature ovariecton-mized female rats. J Ethnopharmacol 2022;282:114579.10.1016/j.jep.2021.114579Suche in Google Scholar PubMed
33. Echeverria, V, Echeverria, F, Barreto, GE, Echeverria, J, Mendoze, C. Estrogenic plants: to prevent neurodegeneration and memory loss and other symptoms in women after menopause. Front Pharmacol 2021;12:644103. https://doi.org/10.3389/fphar.2021.644103.Suche in Google Scholar PubMed PubMed Central
34. Patisaul, HB, Jefferson, W. The pros and cons of phytoestrogens. Front Neuroendocrinol 2010;31:400–19. https://doi.org/10.1016/j.yfrne.2010.03.003.Suche in Google Scholar PubMed PubMed Central
35. Marks, KJ, Hartman, TJ, Taylor, EV, Rybak, ME, Northstone, K, Marcus, M. Exposure to phytoestrogens in utero and age at menarche in a contemporary British cohort. Environ Res 2017;155:287–93. https://doi.org/10.1016/j.envres.2017.02.030.Suche in Google Scholar PubMed PubMed Central
36. Zorzela, L, Boon, H, Mior, S, Yager, J, Gross, A, Vohra, S. Serious adverse events associated with pediatric complementary and alternative medicine. Eur J Int Med 2014;6:467–72. https://doi.org/10.1016/j.eujim.2014.05.001.Suche in Google Scholar
37. Koretz, RL, Rotblatt, M. Complementary and alternative medicine in gastroenterology: the good, the bad and the ugly. Clin Gastroenterol Hepatol 2004;2:957–67. https://doi.org/10.1016/s1542-3565(04)00461-6.Suche in Google Scholar PubMed
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Review Article
- The efficacy and safety of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 agonists in pediatric patients with type 2 diabetes: a systematic review
- Original Articles
- Triple burden of malnutrition and role of anaemia in the development of complications associated with type 1 diabetes in Indian children and youth
- Effect of obesity and excessive body fat on glycaemic control in paediatric type 1 diabetes
- Role of pan immune inflammatory value in the evaluation of hepatosteatosis in children and adolescents with obesity
- Secular trends of birth weight and its associations with obesity and hypertension among Southern Chinese children and adolescents
- Insights into the implication of obesity in hypogonadism among adolescent boys
- The association between plasma carnitines and duration of diabetic ketoacidosis treatment in children with type 1 diabetes
- Cathelicidin as a marker for subclinical cardiac changes and microvascular complications in children and adolescents with type 1 diabetes
- Developing a risk assessment tool for identifying individuals at high risk for developing insulin resistance in European adolescents: the HELENA-IR score
- Hemoglobin A1C can differentiate subjects with GCK mutations among patients suspected to have MODY
- Perceptions and use of complementary and alternative medicine in patients with precocious puberty
- Case Reports
- Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus
- Heterozygous CDC73 mutation causing hyperparathyroidism in children and adolescents: a report of 2 cases
- Wolfram syndrome in a young woman with associated hypergonadotropic hypogonadism – A case report
- Continuous glucose monitoring in an infant with panhypopituitarism having hypoglycemia on growth hormone therapy
- Severe consumptive hypothyroidism in hepatic hemangioendothelioma
- Efficacy of aromatase inhibitor therapy in a case with large cell calcifying Sertoli cell tumour-associated prepubertal gynaecomastia
Artikel in diesem Heft
- Frontmatter
- Review Article
- The efficacy and safety of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 agonists in pediatric patients with type 2 diabetes: a systematic review
- Original Articles
- Triple burden of malnutrition and role of anaemia in the development of complications associated with type 1 diabetes in Indian children and youth
- Effect of obesity and excessive body fat on glycaemic control in paediatric type 1 diabetes
- Role of pan immune inflammatory value in the evaluation of hepatosteatosis in children and adolescents with obesity
- Secular trends of birth weight and its associations with obesity and hypertension among Southern Chinese children and adolescents
- Insights into the implication of obesity in hypogonadism among adolescent boys
- The association between plasma carnitines and duration of diabetic ketoacidosis treatment in children with type 1 diabetes
- Cathelicidin as a marker for subclinical cardiac changes and microvascular complications in children and adolescents with type 1 diabetes
- Developing a risk assessment tool for identifying individuals at high risk for developing insulin resistance in European adolescents: the HELENA-IR score
- Hemoglobin A1C can differentiate subjects with GCK mutations among patients suspected to have MODY
- Perceptions and use of complementary and alternative medicine in patients with precocious puberty
- Case Reports
- Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus
- Heterozygous CDC73 mutation causing hyperparathyroidism in children and adolescents: a report of 2 cases
- Wolfram syndrome in a young woman with associated hypergonadotropic hypogonadism – A case report
- Continuous glucose monitoring in an infant with panhypopituitarism having hypoglycemia on growth hormone therapy
- Severe consumptive hypothyroidism in hepatic hemangioendothelioma
- Efficacy of aromatase inhibitor therapy in a case with large cell calcifying Sertoli cell tumour-associated prepubertal gynaecomastia
